|
1
|
Tse E and Kwong YL: NK/T-cell lymphomas.
Best Pract Res Clin Haematol. 32:253–261. 2019.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Gutiérrez A, Caballero MD, Pérez-Manga G
and Rodriguez J: Hematopoietic SCT for peripheral T-cell lymphoma.
Bone Marrow Transplant. 42:773–781. 2008.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Su YJ, Wang PN, Chang H, Shih LY, Lin TL,
Kuo MC, Chuang WY, Wu JH, Tang TC, Hung YS, et al: Extranodal
NK/T-cell lymphoma, nasal type: Clinical features, outcome, and
prognostic factors in 101 cases. Eur J Haematol. 101:379–388.
2018.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Jaffe ES, Nicolae A and Pittaluga S:
Peripheral T-cell and NK-cell lymphomas in the WHO clasification:
Pearls and pitfalls. Mod Pathol. 26 (Suppl 1):S71–S87.
2013.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Aozasa K and Zaki MA: Epidemiology and
pathogenesis of nasal NK/T-cell lymphoma: A mini-review.
ScientificWorldJournal. 11:422–428. 2011.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Suzuki R, Suzumia J, Yamaguchi M, Nakamura
S, Kameoka J, Kojima H, Abe M, Kinoshita T, Yoshino T, Iwatsuki K,
et al: Prognostic factors for mature natural killer (NK) cell
neoplasms: Aggressive NK cell leukemia and extranodal NK cell
lymphoma, nasal type. Ann Oncol. 21:1032–1040. 2010.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Kimura H and Fujiwara S: Overview of
EBV-associated T/NK-cell lymphoproliferative diseases. Front
Pediatr. 6(417)2018.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Park S and Ko YH: Epstein-Barr
virus-associated T/natural killer-cell lymphoproliferative
disorders. J Dermatol. 41:29–39. 2014.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Chen Z, Guan P, Shan T, Ye Y, Gao L, Wang
Z, Zhao S, Zhang W, Zhang L, Pan L, et al: CD30 expression and
survival in extranodal NK/T-cell lymphoma: A systematic review and
meta-analysis. Oncotarget. 9:16547–16556. 2018.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Boda D: Cellomics as integrative omics for
cancer. Curr Proteomics. 10:237–245. 2013.
|
|
11
|
Ion A, Popa IM, Papagheorghe LM, Lisievici
C, Lupu M, Voiculescu V, Caruntu C and Boda D: Proteomic approaches
to biomarker discovery in cutaneous T-cell lymphoma. Dis Markers.
2016(9602472)2016.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Shimizu I, Hamano Y, Sato S, Takeda W,
Kirihara T, Sato K, Ueki T, Hiroshima Y, Sumi M, Ueno M, et al:
Neurolymphomatosis in a patient with extranodal NK/T-cell lymphoma,
nasal-type: A case report and literature review. Intern Med.
53:471–475. 2014.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Tailor TD, Gupta D, Dalley RW, Keene CD
and Anzai Y: Orbital neoplasms in adults: Clinical, radiologic, and
pathologic review. Radiographics. 33:1739–1758. 2013.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Hwang ST, Janik JE, Jaffe ES and Wilson
WH: Mycosis fungoides and Sézary syndrome. Lancet. 371:945–957.
2018.
|
|
15
|
Cioplea M, Caruntu C, Zurac S, Bastian A,
Sticlaru L, Cioroianu A, Boda D, Jugulete G, Nichita L and Popp C:
Dendritic cell distribution in mycosis fungoides vs. inflammatory
dermatosis and other T-cell skin lymphoma. Oncol Lett.
17:4055–4059. 2019.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Khariwala SS, Litman DA, McQuone SJ, Hess
JL and Thaler ER: Quiz case 2. Natural killer (NK) cell/peripheral
T-cell lymphoma. Arch Otolaryngol Head Neck Surg. 126:1391–1393.
2000.PubMed/NCBI
|
|
17
|
Kommalapati A, Tella SH, Ganti AK and
Armitage JO: Natural Killer/T-cell neoplasms: Analysis of
incidence, patient characteristics, and survival outcomes in the
United States. Clin Lymphoma Myeloma Leuk. 18:475–479.
2018.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Kim BS, Kim TY, Kim CW, Kim JY, Heo DS,
Bang YJ and Kim NK: Therapeutic outcome of extranodal NK/T-cell
lymphoma initially treated with chemotherapy-result of chemotherapy
in NK/T-cell lymphoma. Acta Oncol. 42:779–783. 2003.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Ciobotaru OR, Lupu MN, Rebegea L,
Ciobotaru OC, Miulescu M and Kamel E: Dexamethasone-chemical
structure and mechanisms of action in prophylaxis of postoperative
side effects. Rev Chim (Bucharest). 70:843–847. 2019.
|
|
20
|
Tse E and Kwong YL: Practical management
of natural killer/T-cell lymphoma. Curr Opin Oncol. 24:480–486.
2012.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Chim CS, Ma SY, Au WY, Choy C, Lie AKW,
Liang R, Yau CC and Kwong YL: Primary nasal natural killer cell
lymphoma: Long-term treatment outcome and relationship with the
International Prognostic Index. Blood. 103:216–221. 2004.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Lin HN, Liu CY, Pai JT, Chang FP, Yang CF,
Yu YB, Hsiao LT, Chiou TJ, Liu JH, Gau JP, et al: How to predict
the outcome in mature T and NK cell lymphoma by currently used
prognostic models? Blood Cancer J. 2(e93)2012.PubMed/NCBI View Article : Google Scholar
|
